Neurocrine Bioscience buy StockNews.com
Start price
22.07.23
/
50%
€89.78
Target price
22.07.24
-
Performance (%)
44.07%
Price
08.05.24
€129.35
Summary
This prediction is currently active. With a performance of 44.07% the BUY prediction by StockNews_com is a big success. This prediction currently runs until 22.07.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 0.388% | 0.388% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
Comments by StockNews_com for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by StockNews_com for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
23.09.23
23.09.23
-
23.09.24
23.09.24
19.94%
08.05.24
08.05.24